Brachytherapy
Volume 7, Issue 4 , Pages 286-289 , October 2008

Pretreatment prostate-specific antigen velocity is associated with freedom from biochemical recurrence of prostate cancer after low-dose-rate prostate brachytherapy alone

  • Peter J. Rossi

      Affiliations

    • Department of Radiation Oncology, Emory University School of Medicine, Atlanta, GA
    • Corresponding Author InformationCorresponding author. Department of Radiation Oncology, Emory University, 1365 Clifton Avenue, Atlanta, GA 30322. Tel.: +1-404-778-3658; fax: +1-404-778-4139.
  • ,
  • James Urbanic

      Affiliations

    • Department of Radiation Oncology, Wake Forest University School of Medicine, Winston-Salem, NC
  • ,
  • Peter E. Clark

      Affiliations

    • Department of Urology, Vanderbilt University School of Medicine, Nashville, TN
  • ,
  • David L. McCullough

      Affiliations

    • Department of Urology, Wake Forest University School of Medicine, Winston-Salem, NC
  • ,
  • W. Robert Lee

      Affiliations

    • Department of Radiation Oncology, Duke University School of Medicine, Durham, NC

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Received May 2006; received in revised form September 2006; accepted October 2006.

PII: S1538-4721(08)00609-0

doi: 10.1016/j.brachy.2008.08.004

Brachytherapy
Volume 7, Issue 4 , Pages 286-289 , October 2008